Two of the most common biological matrices differ in something fundamental: where they come from. Xenografts are animal-derived; allografts are human-derived. This article explains the distinction and what it means for reconstruction. It is general educational information, not clinical guidance.

Allograft: human donor tissue

An allograft biological matrix is made from human donor tissue, most often dermis — hence human acellular dermal matrix, or ADM. It is decellularised so only the collagen scaffold remains. Because it depends on donated tissue, supply and batch-to-batch consistency are inherently variable, and availability can fluctuate.

Xenograft: animal-derived tissue

A xenograft is derived from an animal source such as bovine pericardium or porcine dermis. Manufactured to specification, xenografts can offer more predictable, consistent material and more reliable supply. The organised collagen of bovine pericardium in particular provides strong mechanical support.

What the difference means in practice

Both routes aim for the same end — a scaffold the body integrates — but they differ in consistency, supply, thickness and handling. Processing quality matters in both cases, since decellularisation and sterilisation determine immunogenicity and how well the structure is preserved.

Where engineered xenografts fit

Modern engineered xenografts such as ExaShape build on the consistency advantage of manufactured tissue and add design features intended to encourage revascularisation, aiming to combine reliable supply with active integration.

The bottom line

Xenograft (animal) and allograft (human) matrices pursue the same goal by different routes, trading off consistency, supply and structure. Judge each product on its own properties — see our selection framework and biological matrix vs. ADM.

This article is general educational information, not clinical guidance. Refer to device instructions for use and current evidence.